PL210450B1 - Zestaw do szczepienia kotowatych przeciwko wirusowi nabytego niedoboru immunologicznego kotów (FIV) oraz zastosowanie plazmidów i wektorów wirusowych zawierających i eksprymujących in vivo polinukleotydy do wytwarzania szczepionki - Google Patents

Zestaw do szczepienia kotowatych przeciwko wirusowi nabytego niedoboru immunologicznego kotów (FIV) oraz zastosowanie plazmidów i wektorów wirusowych zawierających i eksprymujących in vivo polinukleotydy do wytwarzania szczepionki

Info

Publication number
PL210450B1
PL210450B1 PL365742A PL36574202A PL210450B1 PL 210450 B1 PL210450 B1 PL 210450B1 PL 365742 A PL365742 A PL 365742A PL 36574202 A PL36574202 A PL 36574202A PL 210450 B1 PL210450 B1 PL 210450B1
Authority
PL
Poland
Prior art keywords
gag
fiv
vaccine
env
pro
Prior art date
Application number
PL365742A
Other languages
English (en)
Polish (pl)
Other versions
PL365742A1 (en
Inventor
Laurent Bernard Fischer
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Publication of PL365742A1 publication Critical patent/PL365742A1/xx
Publication of PL210450B1 publication Critical patent/PL210450B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL365742A 2001-06-01 2002-05-29 Zestaw do szczepienia kotowatych przeciwko wirusowi nabytego niedoboru immunologicznego kotów (FIV) oraz zastosowanie plazmidów i wektorów wirusowych zawierających i eksprymujących in vivo polinukleotydy do wytwarzania szczepionki PL210450B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0107275A FR2825280B1 (fr) 2001-06-01 2001-06-01 Vaccination contre le virus de l'immunodeficience feline
PCT/FR2002/001809 WO2002096349A2 (fr) 2001-06-01 2002-05-29 Vaccination contre le virus de l'immunodeficience feline

Publications (2)

Publication Number Publication Date
PL365742A1 PL365742A1 (en) 2005-01-10
PL210450B1 true PL210450B1 (pl) 2012-01-31

Family

ID=8863923

Family Applications (1)

Application Number Title Priority Date Filing Date
PL365742A PL210450B1 (pl) 2001-06-01 2002-05-29 Zestaw do szczepienia kotowatych przeciwko wirusowi nabytego niedoboru immunologicznego kotów (FIV) oraz zastosowanie plazmidów i wektorów wirusowych zawierających i eksprymujących in vivo polinukleotydy do wytwarzania szczepionki

Country Status (14)

Country Link
EP (1) EP1418941B9 (de)
JP (1) JP2004535406A (de)
AT (1) ATE473013T1 (de)
AU (1) AU2002314274B2 (de)
BR (1) BRPI0210229B1 (de)
CA (1) CA2448620C (de)
CZ (1) CZ305257B6 (de)
DE (1) DE60236943D1 (de)
DK (1) DK1418941T3 (de)
ES (1) ES2348226T3 (de)
FR (1) FR2825280B1 (de)
PL (1) PL210450B1 (de)
PT (1) PT1418941E (de)
WO (1) WO2002096349A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06005424A (es) 2003-11-13 2007-01-25 Univ Georgia Res Found Metodos para caracterizar virus de enfermedad bursal infecciosa.
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
AU2014312123A1 (en) 2013-08-29 2016-03-17 Temple University Of The Commonwealth System Of Higher Education Methods and compositions for RNA-guided treatment of HIV infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833993A (en) * 1994-04-29 1998-11-10 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
US7255862B1 (en) * 1996-11-14 2007-08-14 Connaught Technology Corporation ALVAC/FIV constructs
BR0011732B1 (pt) * 1999-06-10 2014-02-04 Vacinas de dna para animais de companhia e de esporte
EP1074625A3 (de) * 1999-06-14 2002-01-02 Pfizer Products Inc. DNS impfstoff gegen das immunschwächevirus der Katze

Also Published As

Publication number Publication date
DK1418941T3 (da) 2010-11-01
BRPI0210229B1 (pt) 2016-11-22
JP2004535406A (ja) 2004-11-25
WO2002096349A2 (fr) 2002-12-05
EP1418941B1 (de) 2010-07-07
EP1418941A2 (de) 2004-05-19
ES2348226T3 (es) 2010-12-01
WO2002096349A3 (fr) 2004-03-11
CA2448620C (en) 2013-05-28
EP1418941B9 (de) 2010-10-20
CZ20033229A3 (cs) 2004-03-17
AU2002314274B2 (en) 2008-03-20
DE60236943D1 (de) 2010-08-19
PL365742A1 (en) 2005-01-10
CZ305257B6 (cs) 2015-07-08
CA2448620A1 (en) 2002-12-05
ATE473013T1 (de) 2010-07-15
FR2825280A1 (fr) 2002-12-06
BR0210229A (pt) 2004-07-20
FR2825280B1 (fr) 2005-04-15
PT1418941E (pt) 2010-10-12

Similar Documents

Publication Publication Date Title
CA2605629C (en) Nipah virus vaccines
US20040241191A1 (en) Recombinant vaccine against West Nile virus
AU2009308331C1 (en) Vaccine against African Horse Sickness Virus
KR100805807B1 (ko) 고양이 칼리시바이러스 유전자 및 백신, 특히 재조합 백신
DK1377660T3 (en) Vaccine against nilfeb ervirus
US20040037848A1 (en) Recombinant vaccine against West Nile Virus
US20030096417A1 (en) Vaccination against feline immunodeficiency virus
EP1425305B1 (de) Igf-1 als impfstoffhilfsmittel für katzen, insbesondere gegen feline retroviren
US6541458B1 (en) Feline calicivirus genes and vaccines in particular recombinant vaccines
CA2448620C (en) Vaccination against the feline immunodeficiency virus
US20050031641A1 (en) Recombinant vaccine against West Nile Virus
AU2014218358B2 (en) Vaccine against african horse sickness virus
AU2008201425A1 (en) Vaccination against the feline immunodeficiency virus
US7326417B2 (en) IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
ZA200201233B (en) Feline calicivirus genes and vaccines, in particular recombined vaccines.
HK1219412B (en) Vaccine against west nile fever